Explaining and Elevating the Role of the Pediatric Nurse Practitioner in Managing Atopic Dermatitis in Children – Monday, November 4, 2024

Join Dr. Peter Lio for a virtual CME lecture on atopic dermatitis!

Monday, November 4, 2024
6:00 PM – 7:00 PM PDT

Course Information

PROVIDER STATEMENT

    

This activity is provided by Integrity CE, LLC. (ACCME Credit)
This activity is jointly provided by Global Education Group and Integrity CE, LLC. (AANP Credit)

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

PROGRAM OVERVIEW

Rashes…pediatric nurse practitioners (PNPs) see them all the time. However, atopic dermatitis (AD), also known as eczema, is not just any rash. It is a disease caused by an inflammatory immune response that affects much more than just the skin. It can have severe, lifelong consequences in all aspects of children’s lives. Fortunately, there are now many effective treatments for even the most severe cases and youngest children — down to 6 months of age. This gives PNPs an important role to play in the therapeutic management of infants, children, and adolescents who are affected by AD. Join pediatric AD expert Dr. Peter Lio for the latest advancements in treatment, curated specifically for PNPs.

Learning Objectives

TARGET AUDIENCE

This educational activity is designed for pediatric nurse practitioners and other healthcare providers involved in managing care for children and adolescents with AD, including primary care physicians, family physicians, and physician assistants.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Delineate the role of pediatric nurse practitioners in diagnosing and managing AD
  • Differentiate between AD severity levels to determine which patients may need referral to a specialist
  • Develop practical strategies for enhancing adherence to and monitoring of treatments for AD that are FDA approved specifically for pediatric populations
Faculty Information and Disclosures

FACULTY

Peter Lio, MD, FAAD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Founding Director, Chicago Integrative Eczema Center
Founding Partner, Medical Dermatology Associates of Chicago
Chicago, Illinois

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC and Global Education Group (Global) require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC and Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Peter Lio, MD, FAAD
Advisory Boards: AbbVie, Admiral, Alphen Biologics, Amyris, AR cutis, ASLAN, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosciences, Dermavant, Eli Lilly, Galderma, Janssen, Johnson & Johnson, Kimberly Clark, LEO Pharma, Lipidor, L’Oréal, Merck, Micreos, Mayor Diagnostics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Sonica, Sūneco Technologies, Theraplex, UCB, Unilever, Verdant Scientific, Verrica, Yobee Care​
Patent Holder: Theraplex AIM (patent pending)​
Research: AbbVie, AOBiome​
Speaker: AbbVie, AR cutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, ​La Roche-Posay/L’Oréal, Mayor ​
Stock Options: Codex Labs, Concerto Biosciences, Sūneco Technologies, Yobee Care, Verdant Scientific [None have had contact with the FDA]

The Integrity CE, LLC and Global Education Group planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME/CE credit for this activity. To receive credit, participants must:

  • Read the learning objectives
  • Complete the pretest
  • View the live broadcast
  • Complete the posttest evaluation form at the end of the program

A statement of credit will be issued only upon receipt of a completed posttest and activity evaluation form. Your certificate will be sent to you via email within four weeks of receipt of the completed evaluation.

ACCREDITATION STATEMENT

Physician Continuing Education

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integrity CE, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.1 hour(s) of pharmacology).

INTEGRITY CE, LLC CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

GLOBAL EDUCATION GROUP CONTACT INFORMATION

For information about the approval (AANP credit) of this program, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC, and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)

Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS

Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:

Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the webcast, you can access the event at this link: https://integrityce.com/AD4Pre

There are no fees for participating and receiving CME/CE credit for this activity. For your participation, you will be able to receive a maximum of 1.0 CME/CE credit. To do so, you must participate in the live-virtual symposium and complete the posttest and evaluation following the event. A statement of credit will be issued via email within four weeks of submission of a completed activity evaluation form.